Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2013
10/03/2013WO2013149010A1 Enhanced antimicrobial lytic activity of a chimeric ply187 endolysin
10/03/2013WO2013148583A1 Binding proteins to the constant region of immunoglobulin g
10/03/2013WO2013148579A1 Pegylated c-peptide
10/03/2013WO2013148332A1 Nutritive fragments and proteins with low or no phenylalanine and methods
10/03/2013WO2013148331A1 Charged nutritive fragments, proteins and methods
10/03/2013WO2013148330A1 Nutritive fragments, proteins and methods
10/03/2013WO2013148329A1 Charged nutritive proteins and methods
10/03/2013WO2013148328A1 Nutritive proteins and methods
10/03/2013WO2013148325A1 Nutritive fragments, proteins and methods
10/03/2013WO2013148321A1 Anti-sigmas for programmable transcriptional regulation
10/03/2013WO2013148316A1 Biomarkers for use in integrin therapy applications
10/03/2013WO2013148272A1 A NOVEL INTERFERON-λ4 (IFNL4) PROTEIN, RELATED NUCLEIC ACID MOLECULES, AND USES THEREOF
10/03/2013WO2013148250A1 Tem-1 diagnostic antibodies
10/03/2013WO2013148248A1 Protease-regulated antibodies
10/03/2013WO2013148224A1 Anti-tumor properties of dickkopf 3b
10/03/2013WO2013148214A1 Modulating disease through genetic engineering of plants
10/03/2013WO2013148198A1 Methods of treating cancer having an active wnt/beta - catenin pathway
10/03/2013WO2013148164A1 Computationally optimized broadly reactive antigens for h5n1 and h1n1 influenza viruses
10/03/2013WO2013148100A1 C-raf mutants that confer resistance to raf inhibitors
10/03/2013WO2013148049A1 Recombinant cytotoxic t-lymphocyte-associated protein 4 (ctla4)
10/03/2013WO2013147793A1 Methods and compositions for modulating notch activity
10/03/2013WO2013147691A1 Affinity chromatography matrix
10/03/2013WO2013147606A1 Combinatorial gamma 9 delta 2 t cell receptor chain exchange
10/03/2013WO2013147584A1 Antiviral composition against flavivirus
10/03/2013WO2013147233A1 Method for producing reagent for antibody detection and use thereof
10/03/2013WO2013147232A1 Bionanocapsule having antibody against surface protein of dendritic cell
10/03/2013WO2013147123A1 C1q-ADIPONECTIN COMPLEX AND USE THEREOF
10/03/2013WO2013147049A1 Novel artificial lipopeptide
10/03/2013WO2013146993A1 Method for detecting degree of malignancy of circulating tumor cell unit, and kit for same
10/03/2013WO2013144704A1 Immunomodulating cyclic compounds from the bc loop of human pd1
10/03/2013WO2013144685A1 Secretion of functional insulin glargine directly into the culture medium through over expression of kex2p intracellularly
10/03/2013WO2013144636A1 Epsilon toxin epitopes from clostridium perfringens with reduced toxicity
10/03/2013WO2013144595A1 Peridinin-chlorophyll binding proteins
10/03/2013WO2013144579A1 Use of flagellin as a vaccine
10/03/2013WO2013144413A1 Calcium sensors and methods for detecting intracellular free calcium
10/03/2013WO2013144412A1 System for conveying antigenic molecules in recombinant polymers similar to elastin
10/03/2013WO2013144345A2 Toll-like receptor 2 binding epitope and binding members thereto
10/03/2013WO2013144165A1 TRANSGENIC IMMUNODEFICIENT MOUSE EXPRESSING HUMAN SIRPα
10/03/2013WO2013143876A1 Fviia-stf complexes exhibiting exosite-mediated super activity
10/03/2013WO2013143077A1 Method for purifying mussel adhesive protein through multi-mode chromatography
10/03/2013WO2013143021A1 Use of xanthomonas campestris effector protein as uridine monophosphate transferase
10/03/2013WO2013142982A1 Colca1 and colca2 and their use for the treatment and risk assessment of colon cancer
10/03/2013WO2013142968A1 Compositions, methods, and plant genes for the improved production of fermentable sugars for biofuel production
10/03/2013WO2013142965A1 Sh2 domain variants
10/03/2013WO2013142961A1 Egfl7 targeting and/or binding polypeptides and methods for inhibiting angiogenesis
10/03/2013WO2013142901A1 Silk polypeptides
10/03/2013WO2013113911A3 Nucleotide sequences involved in plant pest resistance
10/03/2013WO2013098164A3 Novel organic-anorganic composite materials as a result of biomineralisation
10/03/2013WO2013090356A3 Opsin polypeptides and methods of use thereof
10/03/2013WO2002079425A3 Transgenic mice containing clcn4 chloride ion channel gene disruptions
10/03/2013US20130263328 Gene involved in the development of the seed
10/03/2013US20130263327 Modified Helianthus Annuus Transcription Factor Improves Yield
10/03/2013US20130261259 Genetically encoded initiator for polymer growth from proteins
10/03/2013US20130261061 Method of enhancing efficacy of blood transfusions
10/03/2013US20130261060 Serene Protease Derivatives and Uses in the Prevention or the Treatment of Blood Coagulation Disorders
10/03/2013US20130261054 Methods for treatment of nephrotic syndrome and related conditions
10/03/2013US20130261053 Glial cell line-derived neurotrophic factor (gdnf) compositions and use thereof
10/03/2013US20130261049 Alphabodies specifically binding to class-i viral fusion proteins and methods for producing the same
10/03/2013US20130261013 Compounds and Methods
10/03/2013US20130260994 Transgenic plants expressing modified cry3a
10/03/2013US20130260456 Recombinant proteins having haemostatic activity and capable of inducing platelet aggregation
10/03/2013US20130259892 Strongly inactivated and still highly immunogenic vaccine and process of manufacturing thereof
10/03/2013US20130259890 Plasmodium falciparum circumsporozoite vaccine gene optimization for soluble protein expression
10/03/2013US20130259889 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
10/03/2013US20130259887 Reovirus vaccines and methods of use therefor
10/03/2013US20130259869 Rearranged tt virus molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity
10/03/2013US20130259863 Tfpi inhibitors and methods of use
10/03/2013US20130259861 Treatment of autoimmune disorders
10/03/2013US20130259833 AAV-Mediated Subcellular Targeting of Heterologous Rhodopsins in Retinal Ganglion Cells
10/03/2013US20130259802 Radiofluorinated compounds and their preparation
10/03/2013US20130259801 Serum amyloid p protein
10/02/2013EP2644701A1 Methods to improve vector expression and genetic stability
10/02/2013EP2644697A1 Neuron-specific retrograde transport vector
10/02/2013EP2644696A1 Method of increasing replication of a reassortant influenza virus in eggs.
10/02/2013EP2644620A1 Non-fibrillar collagen molded body and method for producing same
10/02/2013EP2644619A1 Monomeric N-terminal spider silk protein domain and uses thereof
10/02/2013EP2644616A1 Method for producing web protein, a fused protein, recombinant dna, an expression vector, a host cell and strain-producers
10/02/2013EP2644027A1 Transgenic immunodefficient mouse expressing human SIRPalpha.
10/02/2013EP2643349A1 Designed repeat proteins binding to serum albumin
10/02/2013EP2643348A2 Improved capping modules for designed ankyrin repeat proteins
10/02/2013EP2643347A1 Modulation of antigen immunogenicity by deleting epitopes recognized by nkt cells
10/02/2013EP2643346A1 Modulation of antigen immunogenicity by addition of epitopes recognized by nkt cells
10/02/2013EP2643345A2 Immunogenic peptides for use in the prevention and/or treatment of infectious diseases, autoimmune diseases, immune responses to allofactors, allergic diseases, tumors, graft rejection and immune responses against viral vectors used for gene therapy or gene vaccination
10/02/2013EP2643344A1 Human lactoferrin derived peptide for use as an antigen masking agent
10/02/2013EP2643343A1 Identification of a human gyrovirus and applications.
10/02/2013EP2643015A1 Compositions and methods
10/02/2013EP2643013A1 Covalently linked interleukin-10
10/02/2013EP2484365B1 Compositions and method for treatment of neovascular diseases
10/02/2013EP2261377B1 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in RNA viruses having class I membrane fusogenic envelope proteins
10/02/2013DE102004037611B4 Induzierbare Genexpression Inducible gene expression
10/02/2013CN103339151A Polyvalent chimeric OspC vaccinogen and diagnostic antigen
10/02/2013CN103339148A Alphabodies specifically binding to cytokines or growth factors and/or cytokine or growth factor receptors
10/02/2013CN103339144A Caspase-2 inhibitors
10/02/2013CN103339143A Hypoallergenic polypeptides for the treatment of house dust mite allergy
10/02/2013CN103339142A Drug delivery material capable of passing through blood-brain barrier, and peptide and use thereof
10/02/2013CN103338785A Bvdv疫苗 Bvdv vaccine
10/02/2013CN103338657A Composition comprising heat labile milk proteins and process for preparing same
10/02/2013CN103333938A Recombinant saccharomyces-fermentum-expressed hepatitis B surface antigen, production method of hepatitis B surface antigen, hepatitis B vaccine and production method of hepatitis B vaccine
10/02/2013CN103333912A Method for implementing constitutive expression of plectasin derivative MP1102 in Pichia pastoris
10/02/2013CN103333911A Method for producing protein A by utilizing recombinant pichia pastoris
1 ... 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 ... 2916